Systematic Laryngoscopic Evaluation of Upper Airways in Ventilated ALS Patients in Portugal and in Norway
2 other identifiers
interventional
60
2 countries
2
Brief Summary
The study examines if titration of Non-Invasive mechanical ventilation (NIV) settings during ongoing laryngoscopic visualization can improve the compliance of NIV in subjects with Amyotrophic Lateral Sclerosis (ALS). The study is a multicentre study between Norwegian National Advisory Unit on Long-term Mechanical Ventilation at the Thoracic Department, Haukeland University Hospital, Bergen, Norway and Centro Hospital Tras-os-Montes e Alto Douro, Vila Real, Portugal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2019
CompletedStudy Start
First participant enrolled
March 21, 2019
CompletedFirst Posted
Study publicly available on registry
March 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMarch 2, 2021
March 1, 2021
2.8 years
March 15, 2019
March 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Apnoea-hypopnea index (AHI)
Change in number of apnea and hypopnea events per hour of sleep
Baseline, one and three months after the intervention.
Time of NIV use
Change in median daily and average daily of hours, minutes
Baseline, one and three months after the intervention.
NIV Leaks
Change in median and 95%
Baseline, one and three months after the intervention.
NIV time of use
Change in % of time of use \> than 4 hours/day
Baseline, one and three months after the intervention.
NIV compliance
Change in number of interruptions, complains and ventilator adjustments
Baseline, one and three months after the intervention.
Secondary Outcomes (2)
Night-time pulseoximeter
Baseline, one and three months after the intervention.
Night-time capnography
Baseline, one and three months after the intervention.
Study Arms (1)
NIV settings titration
OTHERTransnasal Fiberoptic Laryngoscopy will be used during ongoing NIV setting titration. Aim is to titrate NIV setting to be more optimal for laryngeal responses.
Interventions
Use of Transnasal Fiberoptic Laryngoscopy during NIV titration to optimalize the NIV settings to laryngeal responses during the NIV treatment.
Eligibility Criteria
You may qualify if:
- Patients diagnosed Amyotrophic Lateral Sclerosis (ALS) due to El Escorial criteria
- Must have already established Non-invasive ventilation (NIV)
You may not qualify if:
- Ages under 18 years
- Unstable ischemic heart disease
- Oncological disease
- Ventilatory support dependency (more than 16h per day)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tiina Maarit Andersenlead
- University of Trás-os-Montes and Alto Dourocollaborator
- Universidade do Portocollaborator
- Haukeland University Hospitalcollaborator
Study Sites (2)
Norwegian National Advisory Unit on Long-term Mechanical Ventilation at Thoracic Department, Haukeland University Hospital
Bergen, Hordaland, 5021, Norway
Centro Hospitalar Tras-os-Montes e Alto Douro
Vila Real, Portugal
Related Publications (5)
Andersen T, Sandnes A, Brekka AK, Hilland M, Clemm H, Fondenes O, Tysnes OB, Heimdal JH, Halvorsen T, Vollsaeter M, Roksund OD. Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis. Thorax. 2017 Mar;72(3):221-229. doi: 10.1136/thoraxjnl-2015-207555. Epub 2016 May 12.
PMID: 27174631BACKGROUNDAndersen TM, Sandnes A, Fondenes O, Nilsen RM, Tysnes OB, Heimdal JH, Clemm HH, Halvorsen T, Vollsaeter M, Roksund OD. Laryngeal Responses to Mechanically Assisted Cough in Progressing Amyotrophic Lateral Sclerosis. Respir Care. 2018 May;63(5):538-549. doi: 10.4187/respcare.05924. Epub 2018 Apr 17.
PMID: 29666294BACKGROUNDAndersen TM, Sandnes A, Fondenes O, Clemm H, Halvorsen T, Nilsen RM, Tysnes OB, Heimdal JH, Vollsaeter M, Roksund OD. Laryngoscopy Can Be a Valuable Tool for Unexpected Therapeutic Response in Noninvasive Respiratory Interventions. Respir Care. 2018 Nov;63(11):1459-1461. doi: 10.4187/respcare.06674. No abstract available.
PMID: 30389835BACKGROUNDConde B, Martins N, Brandao M, Pimenta AC, Winck JC. Upper Airway Video Endoscopy: Assessment of the response to positive pressure ventilation and mechanical in-exsufflation. Pulmonology. 2019 Sep-Oct;25(5):299-304. doi: 10.1016/j.pulmoe.2019.02.008. Epub 2019 Apr 16.
PMID: 31000441BACKGROUNDAndersen TM, Halvorsen T, Fondenes O, Heimdal JH, Roksund OD, Vollsaeter M, Roksund OD. Larynx: The Complex Gateway to the Lungs. Respir Care. 2019 Jul;64(7):866-869. doi: 10.4187/respcare.06989. No abstract available.
PMID: 31243162BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tiina M Andersen, PhD
Haukeland University Hospital
- PRINCIPAL INVESTIGATOR
Bebiana Conde, PhD fellow
Centro Hospitalar Tras-os-Montes e Alto Douro
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Respiratory Physiotherapist, PhD
Study Record Dates
First Submitted
March 15, 2019
First Posted
March 22, 2019
Study Start
March 21, 2019
Primary Completion
December 31, 2021
Study Completion
December 31, 2022
Last Updated
March 2, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share
Since the study examines patients with a rare disease in the defined geographical areas, we need to be careful not to share data that can be identifiable. A study protocol, informed consent forms and data analysis plan will be available within 6 months of study completion.